521 — St Louis, Missouri

521 is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

521 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Sponsors: Corcept Therapeutics.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 521?

521 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 521 conducted?

521 has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Is 521 accredited by Crixeo Health?

521 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 521?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.